相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Suspected Levetiracetam-Induced Rhabdomyolysis: A Case Report and Literature Review
Imran A. Moinuddin
AMERICAN JOURNAL OF CASE REPORTS (2020)
Rhabdomyolysis Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
Chengwen Teng et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2019)
Levetiracetam-induced rhabdomyolysis: the first Italian case
Eugenia Rota et al.
NEUROLOGICAL SCIENCES (2018)
Rhabdomyolysis: A Rare Averse Effect of Levetiracetam
Vaibhav Rastogi et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2018)
A case of rhabdomyolysis in which levetiracetam was suspected as the cause
Hisanao Akiyama et al.
EPILEPSY & BEHAVIOR CASE REPORTS (2014)
Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review
Gashirai K. Mbizvo et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Retrograde influence of muscle fibers on their innervation revealed by a novel marker for slow motoneurons
Joe V. Chakkalakal et al.
DEVELOPMENT (2010)
The syndrome of rhabdomyolysis: Complications and treatment
Yiannis S. Chatzizisis et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2008)
Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures
S. Noachtar et al.
NEUROLOGY (2008)
Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy
S. F. Berkovic et al.
NEUROLOGY (2007)
The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
BA Lynch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)